F11 receptor (f11r) antagonists as therapeutic agents
AssigneeThe Research Foundation for The State University of New York
InventorsElizabeth Kornecki, Anna Babinska, Yigal H. Ehrlich
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound including a peptidomimetic which interacts sterically with the binding site of a F11R molecule, the peptidomimetic including a peptidomimetic having the SEQ ID NO: 4D. The present invention also provides a method for treating a disorder comprising administering peptide 4D to a mammal.
Claims2
A compound comprising a peptidomimetic which interacts sterically with the binding site of a F11R molecule, wherein the peptidomimetic has a sequence selected from the group consisting of dKSVTdREDTGTYTC-CONH2, KSVTdREDTGTYTC-CONH2, SVTdREDTGTYTC-CONH2, VTdREDTGTYTC-CONH2, TdREDTGTYTC-CONH2, dREDTGTYTC-CONH2, REDTGTYTC-CONH2, EDTGTYTC-CONH2, DTGTYTC-CONH2, TGTYTC-CONH2, GTYTC-CONH2, dKSVTdREDTGTYTC, dKSVTdREDTGTYT, dKSVTdREDTGTY, dKSVTdREDTGT, dKSVTdREDTG, dKSVTdREDT, dKSVTdRED, dKSVTdRE, dKSVTdR, dKSVTd and dKSVT.
Dependencies are inferred from the claim text.